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Background: Colorectal cancer is common in North America. Two surgical options exist for rectal cancer patients:
low anterior resection with re-establishment of bowel continuity, and abdominoperineal resection with a permanent
stoma. A rectal cancer decision aid was developed using the International Patient Decision Aid Standards to facilitate
patients being more actively involved in making this decision with the surgeon. The overall aim of this study is to
evaluate this decision aid and explore barriers and facilitators to implementing in clinical practice.
Methods: First, a pre- and post- study will be guided by the Ottawa Decision Support Framework. Eligible patients
from a colorectal cancer center include: 1) adult patients diagnosed with rectal cancer, 2) tumour at a maximum
of 10 cm from anal verge, and 3) surgeon screened candidates eligible to consider both low anterior resection
and abdominoperineal resection. Patients will be given a paper-version and online link to the decision aid to review at
home. Using validated tools, the primary outcomes will be decisional conflict and knowledge of surgical options.
Secondary outcomes will be patient’s preference, values associated with options, readiness for decision-making,
acceptability of the decision aid, and feasibility of its implementation in clinical practice. Proposed analysis includes
paired t-test, Wilcoxon, and descriptive statistics.
Second, a survey will be conducted to identify the barriers and facilitators of using the decision aid in clinical practice.
Eligible participants include Canadian surgeons working with rectal cancer patients. Surgeons will be given a
pre-notification, questionnaire, and three reminders. The survey package will include the patient decision aid
and a facilitators and barriers survey previously validated among physicians and nurses. Principal component
analysis will be performed to determine common themes, and logistic regression will be used to identify variables
associated with the intention to use the decision aid.
Discussion: This study will evaluate the impact of the rectal cancer decision aid on patients and help with planning
strategies to overcome barriers and facilitate implementation of the decision aid in routine clinical practice. To our
knowledge this is the first study designed to evaluate a decision aid in the field of colorectal surgery.
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Colorectal cancer is the third most common cancer
accounting for 13% all new cancer diagnoses in Canada
[1]. Rectal cancer comprises any tumor in the last 15 cm
of the large intestine. The treatment of rectal cancer is
especially challenging given the pelvic anatomy and the
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unless otherwise stated.as well as bladder and sexual functions. Two surgical
therapies exist for rectal cancer patients: low anterior re-
section (LAR) with re-establishment of bowel continuity,
and abdominoperineal resection (APR) with a perman-
ent stoma. Each procedure presents a particular set of
benefits and risks. While LAR is associated with higher
risks of leakage at the intestinal re-connection and fecal
incontinence; APR is associated with higher risks of
stoma related hernia, prolapse, skin damage, and surgery
related infections [2]. LAR combined with neoadjuvant
therapy has seen a significant rise in surgical practices,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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in patient survival when compared to APR [2]. Although
it was once believed that avoiding a permanent stoma
would improve quality of life, recent literature has ques-
tioned the validity of that claim [3-6].
A meta-analysis identified APR as having better global
psychological and emotional scores, while LAR was
associated with better physical symptom and pain scores.
However, results for overall quality of life (QoL), despite
being measured by various validated instruments, were
consistently equivocal [7]. Similarly, a recently updated
Cochrane Review has revealed that low anterior resec-
tion (LAR) did not lead to superior QoL [8]. Given the
equivalent survival outcomes, and the need to weigh
QoL outcomes, the decision for rectal cancer surgery is
therefore a value-laden one that deserves the consider-
ation of the patient perspective.
Evidence suggests that patients have played a passive
role in the decision process: the decision traditionally
relies on three factors including 1) patient’s baseline
functional status, 2) surgeon preference, and 3) tumour
characteristics [7]. Greater involvement of patients in
decision-making may lead to higher quality decisions
congruent with patient preferences.
Shared decision making (SDM) is a model that seeks
to include both the patients and their healthcare pro-
viders in the decision making process [9]. It encourages
patients to play an active role in decisions concerning
their health, which is a goal of patient-centered care
[10]. This model of care has been endorsed by the recent
Salzburg Declaration [11] and the US National Academy
recommendations on State and Federal SDM implemen-
tation [12]. SDM can be facilitated by patient decision
aids (PtDA), which are defined as interventions designed
to help people make specific and deliberative choices
among options by providing information on the options
and outcomes relevant to the patient’s health status [13].
The effectiveness of PtDA has been demonstrated in at
least three separate systematic reviews [14,15]. They
have been shown to improve patient knowledge, lower
decisional conflict related to feeling uninformed and
unclear about personal values, reduce the proportion
of people who were passive in decision making post-
intervention, and improve agreement between patient
values and health care option chosen [14]. Furthermore,
exposure to decision aids can lead to a higher proportion
of people with accurate risk perceptions [14]. Despite
the demonstrated value of decision aids, a thorough
search through the Ottawa Decision Support A to Z
Inventory and Decision Aid Library Inventory (DALI)
[16], comprehensive catalogues of decision aids, did not
return any decision tools to engage rectal cancer patients
in the decision-making process regarding the most
appropriate surgical treatment for them.In 2003, consensus standards for PtDAs were estab-
lished by the International Patient Decision Aid Standards
Collaboration (IPDAS) [17]. Through the Delphi method,
the IPDAS involved over 100 major stakeholders such as
patients, practitioners, researchers and policy makers to
develop the criteria for the assessment of the quality of
PtDAs. The Ottawa Decision Support Framework (ODSF)
is a decision making framework informed by cognitive,
social, and organizational psychological theory that guides
the assessment and development of PtDAs [18]. This
framework contributed to the development of the IPDAS
[19]. Guidelines [20] put forth by the ODSF have been
used in the development of at least 31 decision aids that
were involved in 24 randomized controlled trials [21]. Ad-
hering to quality criteria set by the IPDAS and using the
ODSF as a template, a rectal cancer PtDA was developed
(Additional file 1) following three principal steps: 1) A sys-
tematic review to explore the long term side effects of
rectal cancer surgeries; 2) Needs assessments on rectal
cancer patients and colorectal surgeons; 3) Development
of a decision aid. The systematic review identified that
bowel dysfunction after surgical therapies was high [22].
The needs assessments identified a lack of awareness of
surgical options and their outcomes, as well as a general
lack of patient involvement in the decision making process
[23]. The needs assessment also identified that despite the
practitioners expressing commitment to shared decision
making, their view of the population to which this could
apply was limited. The need for a rectal cancer decision
aid was identified to encourage quality communication
between patients and their practitioners. The decision aid
was then designed by integrating evidence-based know-
ledge on the benefits and risks associated with LAR and
APR. Since development, its content and presentation
have been reviewed by a patient and a surgeon, but it has
not been formally evaluated.
As the rectal cancer decision aid has been developed,
the current study is the next step with aims to evaluate
and implement the decision aid. The first phase of the
proposed study will continue to follow recommendations
of the ODSF to evaluate the decision aid with patients at
the point of decision making [20] via a pre- and post-
DA design.
Adoption of evidence does not solely rely on the
evaluation from patients, as decision making is a process
that involves both the patients and the healthcare pro-
fessionals. Patients’ input is necessary but their percep-
tion alone has not been sufficient to change clinical
practice [24,25]. It is not surprising that even though pa-
tient decision aids may foster SDM [26,27], it has been
shown that wide spread use in clinical practice has been
poor [28-30]. Given the effectiveness of PtDAs, signifi-
cantly more effort is needed to understand the factors
preventing their integration into clinical practice [31].
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iterative guiding framework to outline strategies for
implementation and application of knowledge [32,33].
It is a framework used by the Canadian Institutes of
Health Research (CIHR) for transfer of research find-
ings into practice [34]. It promotes the identification
of potential barriers as a necessary step prior to devel-
oping an implementation strategy for the wide use of
an intervention [32].
Furthermore to maintain practice change, there needs
to be interventions designed to address the contextual
factors that may affect the implementation [35]. A sys-
tematic review reported that the three most commonly
cited barriers by health professionals are: 1) time pres-
sure; 2) lack of SDM applicability due to patient charac-
teristics; 3) lack of SDM applicability due to the clinical
situation [24]. These results indicate that healthcare pro-
fessionals in general are feeling mounting pressure from
limited resources, and that practitioners may be select-
ing patients for SDM. This knowledge helps inform
strategies for future implementation.
To address health professionals’ barriers to use the
rectal cancer decision aid, the second phase of the pro-
posed study will explore the issues perceived by the po-
tential adopters—the surgeons working with rectal
cancer patients in North America. The assessment of fa-
cilitators and barriers specific to the rectal cancer deci-
sion aid will help establish the factors associated with
the healthcare professionals and the practice environ-
ment, and provide direction for selecting and tailoring
implementation strategies.
Taken together, decision aids are a platform for
shared decision making, an important goal for patient-
centred care. Following the guidelines of the Ottawa
Decision Support Framework, a rectal cancer surgery
PtDA has been developed but not evaluated. In
addition, the assessment on patients’ perspective alone
is insufficient for the successful implementation of
the decision aid in a clinical setting. Evidence trans-
lation into clinical practice needs to involve the
healthcare professionals. The current study seeks to
address these two issues by evaluating the decision
aid on patients and exploring the barriers and facili-
tators of implementation.Study objectives
The current thesis study aims to 1) evaluate the effect of
a decision aid on patients’ choice and decision-making
process and 2) explore surgeons perception of the fa-
cilitators and barriers influencing implementation of
the rectal cancer decision aid for patients who are
considering low anterior resection versus abdomino-
perineal resection.Methods
Part 1: pre- and post- PtDA study
Research questions:
1) What is the effect of a decision aid on patients’
choices and decision-making processes, among
rectal cancer patients?
2) What is the acceptability of the rectal cancer
decision aid among patients?
3) What is the feasibility of implementing the decision
aid into usual clinical practice?
Study design
A before and after study will be used to evaluate the
decision aid. A review examining PtDA evaluative stud-
ies showed that before/after studies and randomized
controlled trials have both demonstrated DA effect on
choice, patient comfort with decision making, outcomes
of decisions, and patient acceptability [36]. In addition,
the rectal cancer PtDA was developed according to the
ODSF, which has a strong theoretical foundation that
has been extensively validated [19]. Given the Ottawa
framework has already been evaluated over 20 RCT’s, a
pre- and post- DA design was identified as appropriate
to explore PtDA effect on decisional conflict before and
after intervention, acceptability as perceived by patients,
and the feasibility of implementing the DA into usual
clinical practice.
Participants
The study will take place in a tertiary care hospital serv-
ing a population of 1.3 million people. The Colorectal
Assessment Centre at the Ottawa Hospital receives on
average 12 rectal cancer patient referrals per month.
Approximately half (6/12) of these patients would be eli-
gible for the study. Eligible participants are 1) patients
with newly diagnosed stage I-III rectal cancer confirmed
by biopsy; 2) tumor located at a maximum of 10 cm
proximal to anal verge; 3) surgeon screened candidates
eligible to consider LAR and APR; 4) age ≥ 18; and
5) able to understand and sign informed consent form
in English. Patients with existing or previous stoma
will be excluded.
Study intervention
A self-administered rectal cancer surgery decision aid that
was developed according to the International Patient
Decision Aid Standards (IPDAS) to be used prior to the
consultation with the surgeon. During development, a
systematic review on long-term postoperative bowel
dysfunction and needs assessment were performed and
indicated a need for a rectal cancer surgical decision
aid. Its content was informed by the highest evidence
from existing literature. The decision tool synthesized
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values-clarification exercise and guidance in the steps
of decision making. The goal of the decision aid is to
enhance patients’ knowledge of surgical options, clarify
their values associated with each option, and thus foster
decisions that are value-congruent. The decision aid is
available in paper-based and web-based interactive
formats, using both figures and statistics to convey
evidence-based knowledge. Patients will receive both
versions of the decision aid as part of the intervention
and may choose to use one, or both formats. This
decision aid will be used as an adjunct to counseling
with the health care team.
On the day of return to clinic for surgical consent, a
single page summary sheet will be created based on
collected patient data for use by the surgeon and patient.
Procedure
Recruitment will occur at the initial visit at a Cancer
Assessment Centre. After completing consent, patients
will answer a pre-decision aid questionnaire on paper
for baseline measures on knowledge, preferred choice,
and decisional conflict while in clinic. Participants are
then asked to view the decision aid (paper-based, web-
based, or both) in its entirety (Additional file 1) at home,
and answer a post-decision aid questionnaire (Additional
file 1) (on paper, on the web, or both) that assesses the
acceptability of the decision aid, knowledge, value, deci-
sional conflict, preferred choice, and preparation for
decision-making. In this study, we will aim to obtain
answers from participants within three weeks of their
initial visit at the cancer centre by placing a phone call.
This process can limit the time lapse between the view-
ing of the decision aid and answering the post-PtDA
questions. Patients who do not view the PtDA or who
are difficult to contact within three weeks, will be en-
couraged to send in the answers in a stamped envelope
included in their package.
Instruments
The instruments are used to measure both the choices
and decision making processes among patients, the ac-
ceptability of the decision aid, and feasibility of its imple-
mentation into routine clinical practice. Patient choice
will be measured by the PtDA effect on their knowledge,
values, and preferred choice. Decision making process
will be measured by patients’ decisional conflict and pre-
paredness to have a discussion with a healthcare profes-
sional. The primary outcome, decisional conflict scale
(DCS) [37] -will be measured using the 16 item 5 re-
sponse category instrument. It is robust in construct
validity, reliability with a Cronbach’s alpha coefficient
exceeding 0.78, and is sensitive to change when used as
a single construct [38]. The scale is also subcategorizedinto uncertainty, informed, values clarity, support, and
effectiveness. The value tool was specifically developed for
the decision aid following ODSF guidelines (Additional
file 1). It is a 6 item scale measuring importance placed
on values associated with bowel anastomosis and per-
manent stoma. Answering theses value items will help
clarify patient values associated with each surgical op-
tion. The choice predisposition tool looks at any inclin-
ation towards an option before and after administering
the PtDA [39]. It is measured by a 15 point scale ran-
ging from −7 (towards stoma) to +7 (towards bowel
hookup). It has a test retest coefficient of 0.90 [40] and
is sensitive to change in particularly the undecided par-
ticipants [41-43]. The preparation for decision making
tool is a 10 item scale examines a patient’s perception
on how the PtDA has prepared them to communicate
with practitioner [44]. This tool has a high Cronbach’s
alpha coefficient of 0.92 to 0.96 and total reliability of
0.944 [45]. The acceptability tool is measured by a 7
item scale testing the comprehensibility of components
of a PtDA, including its length, pace, amount of infor-
mation, balance in presentation, and overall suitability
[46]. This tool has face validity and has been used in at
least 8 studies [46]. The decisional conflict, choice pre-
disposition, preparation for decision making scales,
and acceptability tools were obtained from the Ottawa
Decision Support Group (ODSF) [47].Sample size
A convenience sample of patients at The Ottawa Hospital
who have rectal cancer and meet the eligibility criteria will
be invited to participate. A paired t-test will be used to
compare the means of ‘decisional conflict’ score measured
before and after the PtDA implementation. Assuming a
significance level of 0.05, power of 0.80, an expected
standard deviation of 0.6 [38], our required sample size is
34 to detect a clinically relevant difference of 0.3 in the de-
cisional conflict score. The minimal clinical difference for
the DCS scale was previously established because this dif-
ference is able to discriminate people who make decisions
from those who delay decisions in a validation study by
O’Connor [37]. Accounting for a drop out rate of 10%, our
estimated sample size is 38. The study will continue until
the recruitment target of 38 patients has been reached.Outcomes
Primary outcome measure
The primary outcome will be decisional conflict and
knowledge of surgical options. The decisional conflict
scale and knowledge test will be used before and after
decision aid. The mean scores will be compared using
paired t-test. Knowledge test will be a score on 4 questions
reflecting key points in knowledge to make decisions.
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Secondary outcomes will be measured on choice predis-
position, value, preparation for decision making of the
patients, acceptability of the tool, and feasibility of DA
delivery as part of usual clinical practice.
Acceptability of the decision aid among patients, value
score related to each surgical option, and preparation
for decision making score will be summarized and de-
scribed. Preferred choice will be measured before and
after the DA administration and the proportion of
people with change in preference will be described.
Feasibility of DA delivery will be described as manifest
through mean time spent on the pre-decision aid ques-
tionnaire and the impact on subsequent length of surgi-
cal consent visit.
Data will be entered and stored in a database on a
password-protected computer on site. Data checking
will be performed to identify duplications and missing
data. Strategies including case-wise deletion, variable
deletion, and imputation will be considered to handle
missing data. Analysis will be done through SAS 9.2
statistical software.
Ethics approval
This project has been approved by the Ottawa Health
Science Network Research Ethics Board.
Part 2: survey of surgeons and nursing staff
Research question: What are the perceived facilitators
and barriers influencing the implementation of the rectal
cancer decision aid according to the healthcare providers?
Study design
A web-based survey will be guided by the Knowledge to
Action Framework [33] using the survey implementation
method proposed by Couper on Internet survey design
[48]. Knowledge to Action Cycle [34] states that barriers
to knowledge use are important to determine prior to
implementation of knowledge translation tools such as
patient decision aids in clinical practice [33]. An internet
survey is the most feasible option to reach the broad
target population of all Canadian colorectal surgeons
working with rectal cancer patients. Consistent with
other survey methodologists, Couper suggests that sur-
vey implementation should include three stages in pre-
notification, invitation to survey, and follow-up. The
current study will include all three stages.
Sampling frame
Colorectal surgeons in Canada can be identified by
membership with the Canadian Society of Colon and
Rectal Surgeons (CSCRS). This organization has been
contacted and a list of members’ updated emails are
maintained and accessible. There are an estimated 114surgeons registered with CSCRS. Eligible surgeons work-
ing specifically with rectal cancer patients will be identi-
fied by the first question in the online survey.Procedure
An email will be sent to all surgeons in the directory.
Publicly available member lists will be compared to
eliminate potential duplicates. An online survey will be
created via Fluid Surveys. To maximize the response
rate, the survey implementation will follow recommen-
dations of Couper [48], consisting of a pre-notification
email, a personalized email invitation to participate with
the decision aid attached and a link to the online survey,
a reminder email will be sent on days three and six
following the invitation email. A final email reminder to
non-responders will be sent to further encourage re-
sponse on day ten.Instrument
A single survey tool modified from the Facilitators and
Barriers Survey by Graham et al. will be used for physi-
cians [49]. The 41 item survey will be divided into five
main areas: 1) development of the decision aid; 2) con-
tent and format of the decision aid; 3) decision aid and
meeting patients’ needs; 4) physicians’ clinical practice;
5) implementation. All questions will be rated on a 5-point
scale from 1 (strongly agree) to 5 (strongly disagree). There
are two questions asking surgeons how likely they are to
use the decision aid, rated as “not at all” to “very likely”.
Two questions will explore the additional facilitators and
barriers not mentioned in the survey. Two questions will
explore program specific adaptation and further com-
ments. This survey tool was first used in a study of 270
physicians in three different specialties and later modified
for two subsequent studies of nurses. Using principal com-
ponent analysis with Verimax rotation, Graham et al.
showed factorial validity with survey items loaded on four
components including quality and value for patients, value
for physicians, decision aid content, and implementation
issues [49]. The same survey tool was then adapted and
used in studies to assess factors influencing nurses’ use
of decision aid in a primary care call center [50] and an
Australian cancer call center [51].Outcomes
The response rate will be determined. Common barriers
and facilitators to the implementation of the decision aid
will be identified. The primary outcome is intention to
implement the decision aid. The response distribution
will be analysed, and we will identify factors affecting the
intention to implement the decision aid.
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Data will be captured by the online survey software and
downloaded to the study database. Response rate will be
determined based on the total number of completed,
partially completed, refusals and breakoffs, noncontact
(failed to deliver), and unknown eligibility. Ineligibility
will be determined by the first question on the survey
asking respondents to identify whether they are surgeons
working with rectal cancer patients. Non-response rate
will be reported. Descriptive statistics will be used to
generate characteristics of survey respondents. All re-
sponse distribution will be presented.
The intention question on the physicians’ likelihood of
using the decision aid will be dichotomized into a binary
variable with ‘likely’ and ‘very likely’ versus the rest of
the responses. Intention will be subsequently used as a
response variable in a logistic regression model. Princi-
pal component analysis with Verimax rotation will be
performed on all items to confirm common themes and
logistic regression analysis will be used to identify inde-
pendent variables associated with the intention to use
the decision aid. The independent variables will be com-
ponents extracted from principal component analysis.
Item-missing data will be explored and addressed by
casewise deletion, variable deletion, and possibly imput-
ation, depending on its extent and nature. Respondents
presenting with more than half missing values will be
excluded from analysis.Discussion
Shared decision making is a strategy that is being pro-
moted across the healthcare systems in the US and
Canada [52]. Currently the rectal cancer decision aid has
been developed, but has not been formally evaluated.
This study aims to evaluate the decision aid and explore
the perceived barriers and facilitators to the implemen-
tation of the decision aid. It will help with planning
strategies for designing interventions to facilitate imple-
mentation and overcome known barriers to use of the
decision aid in routine clinical practice [32].
Physician/nursing/management collaboration will also
be a major factor in completing the pre- and post- study.
We will hold meetings with surgeons and nursing staff
at the Cancer Assessment Centre to increase awareness
among staff. Information sheets will be available in the
rectal cancer clinics to remind the staff of inclusion &
exclusion criteria of the study.
The single arm pre- and post- design of the study and
the lack of control and blinding pose threat to our ability
to make causal inferences. Nonetheless, important infor-
mation will be obtained on how the rectal cancer DA
may impact the choice and decision-making process of a
patient, the acceptability of the decision tool to patients,and the feasibility of integrating this decision aid into
everyday practice.
For the survey study, low survey response rate may
introduce non-response bias where responders and non-
responders are different. Therefore, this study will at-
tempt to maximize response rate by obtaining accurate
email addresses, using a simple and concise questionnaire,
and sending follow up reminders [48]. Response/non-
response will be reported. Discussion of possible bias will
be an important part of the interpretation of the findings.
The implementation of the decision aid could lead to
more evidence based knowledge dissemination related to
rectal cancer and the surgical choices, less uncertainty
related to decisions, and ultimately decisions more con-
gruent with patients’ values. To our knowledge this is
the first study designed to evaluate a decision aid in the
field of colorectal oncology. The data collected from this
study could lead to more definitive large scale studies on
the surgical decision aid in the future.
Additional file
Additional file 1: The Rectal Cancer Decision Aid and Post-Decision
Aid Questionnaire.
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